Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 25, 2016 - Issue 9
Submit an article Journal homepage
1,299
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Perspectives on investigational drugs and immunotherapies for glioblastoma

Julie J. MillerStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA;Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USAView further author information
,
William T. CurryStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA;Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USAView further author information
,
Dan P. CahillStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA;Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USAView further author information
&
Jörg DietrichStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA;Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
View further author information
Pages 1007-1009 | Received 26 Mar 2016, Accepted 12 Jul 2016, Published online: 18 Aug 2016

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nusrat Jahan, Hammad Talat, Andrea Alonso, Dipongkor Saha & William T. Curry. (2019) Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial glioma. OncoImmunology 8:5.
Read now

Articles from other publishers (1)

Yu-Long Lan, Xun Wang, Jia-Cheng Lou, Jin-Shan Xing, Zhen-Long Yu, Hongjin Wang, Shuang Zou, Xiaochi Ma & Bo Zhang. (2018) Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na+/K+-ATPase α1 subunit. Biomedicine & Pharmacotherapy 103, pages 204-215.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.